Collagen gene expression in the neomatrix of carcinoma of the breast

Invasion and Metastasis

Volumn 16, Issue 6, 1996, Pages 308-316

  Wapnir, Irene L ^a   Southard, Harry ^a   Chen, Guanghua ^a   Friedman, Julia ^a   Boyd, Charles D ^a   Amenta, Peter S ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Collagen; Desmoplasia; In situ hybridization; Invasion

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COMPLEMENTARY DNA; MESSENGER RNA; PROCOLLAGEN;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; TUMOR CELL;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COLLAGEN; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICROSCOPY; NEOPLASM INVASIVENESS;

EID: 0030411239     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Seemayer T, Lagace R, Schurch W, Tremblay G: Myofibroblasts in the stroma of invasive and metastatic carcinoma. Am J Surg Pathol 1979;3:525-533.
2. Liotta L, Rao CN, Barsky S: Tumor invasion and the extracellular matrix. Lab Invest 1983;49:636-649.
3. Barsky S, Green W, Grotendorst G, Liotta L: Desmoplastic breast carcinoma as a source of human myofibroblasts which are positive for type I. Am J Pathol 1984;115:329-333.
4. Page D, Anderson T: Diagnostic Histopathology of the Breast. Edinburgh, Churchill Livingstone, 1987, pp4-10, 89-103, 193-236.
5. Schor S, Schor A: Clonal heterogeneity in fibroblast phenotype: Implications for the control of epithelial-mesenchymal interactions. Bioessays 1987;7:200-204.
6. Sappino A, Schurch W, Gabbiani G: Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990;63:144-161.
7. Ronnov-Jessen L, van Deurs B, Celis JE, Petersen OW: Smooth muscle cell differentiation in cultured human breast gland stromal cells. Lab Invest 1990;63:532-543.
8. Weidner N, Semple J, Welch W, Folkman J: Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-7.
9. Dickson RB, Shi YE, Johnson MD: Matrix-degrading proteases in hormone-dependent breast cancer. Breast Cancer Res Treat 1994;31:167-173.
10. Polette M, Birembaut P: Matrix metalloproteinases in breast cancer. Breast J 1996;2:209-220.
11. Pages A, Foidart JM, Gordenne W, Pages AM, Ponzio J: Localisation des collagènes de types I, III, IV et de la fibronectine dans les tumeurs bénignes et les épithéliomes de la glande mammaire humaine. J Gynécol Obstet Biol Reprod 1984;1:35-40.
12. Deak S, Glaug M, Pierce R, Bancila E, Amenta P, Mackenzie J, Greco R, Boyd C: Desmoplasia in benign and malignant breast disease is characterized by alterations in the levels of mRNA coding for types I and III procollagen. Matrix 1991;11:252-258.
13. Luparello C, Sheterline P, Pucei-Mi-nafra I, Minafra S: A comparison of spreading and motility behaviour of 8701-BC breast carcinoma cell on type-I trimer and type-V collagen substrate: Evidence of permissive effect of type-I trimer collagen on cell locomotion. J Cell Sci 1991;100:179-185.
14. Thompson EW, Yu M, Bueno J, Jin L, Maiti SN, Palao-Marco FL, Pulyaeva H, Tamborlane JW, Tirgari R, Wapnir I, Azzam H: Collagen induced MMP-2 activation in human breast cancer. Breast Cancer Res Treat 1994;31:357-370.
15. Al-Adnani MS, Kirrane JA, McGee JO: Inappropriate production of collagen and prolyl hydroxyproline by human breast cancer in vivo. Br J Cancer 1975;31:653-660.
16. Kao R, Hall J, Stern R: Collagen and elastin synthesis in human stroma and breast carcinoma cell lines: Modulation by the extracellular matrix. Connect Tissue Res 1986;14:245-255.
17. Clavel C, Doco M, Lallemand A, Laurent M, Birembaut P: Detection by in situ hybridization of messenger RNAs of collagen types I and IV in murine mammary cancer. Int J Cancer 1989;44:548-553.
18. Ohtani H, Kuroiwa A, Obinata M, Ooshima A, Nagura H: Identification of type I collagen-producing cells in human gastrointestinal carcinomas by non-radioactive in situ hybridization and immunoelectron microscopy. J Histochem Cytochem 1992;40:1139-1146.
19. Ohtani H, Nagai T, Nagura H: Similarities of in situ mRNA expression between gelatinase A (MMP-2) and type I procollagen in human gastrointestinal carcinoma: Comparison with granulation tissue reaction. Jpn J Cancer Res 1995;86:833-839.
20. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, Wotmark N, Wickerham L, Deutsch M, Ore L, Mamounas E, Poller W, Kavanah M: Lumpectomy compared to lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-1586.
21. Page D, Dupont W, Rogers L, Jensen RA, Schuyler PA: Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995;76:1197-2000.
22. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson IC: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913-918.
23. Martinez-Hernandez A, Francis D, Silverberg S: Elastosis and other stromal reactions in benign and malignant breast tissue. Cancer 1977;40:700-706.
24. Chu M, Myers JC, Bernard MP, Ding J, Ramirez F: Cloning and characterization of five overlapping cDNAs specific for the human pro a 1 (I) collagen chain. Nucleic Acids Res 1982;10:5925-5934.
25. Loidl HR, Brinker JM, May M, Pihlajaniemi T, Morrow S, Rosenbloom J, Myers JC: Molecular cloning and carboxyl-propeptide analysis of human type III procollagen. Nucleic Acids Res 1984;12:9383-9394.
26. Friedman D, Boyd C, Mackenzie JW, Norton P, Olson RM, Deak SB: Regulation of collagen gene expression in keloids and hypertrophic sears. J Surg Res 1993;55:214-222.
27. Amenta PS, Martinez-Hernandez A: Immunological identification of extracellular matrix components in tissues and cultured cells; in Haralson MA, Hassell JR (eds): Extracellular Matrix: A Practical Approach. Oxford, IRL Press, 1995, pp 303-327.
28. Bocker W, Bier B, Freytag G, Brommelkamp B, Jarasch E, Edel G, Dockhorn-Dworniczak B, Schmid KW: An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alphasmooth muscle actin, vimentin, collagen IV and laminin. Virchows Arch A Pathol Anat 1992;421:323-330.
29. Zar JH: Biostatistical Analysis, ed 2. Englewood Cliffs, Prentice-Hall, 1984, pp 162-194.
30. Cuzick J: A Wilcoxon-type test for trend. Stat Med 1985;4:87-90.
31. Lagace R, Grimaud J, Schuren W, Seemayer T: Myofibroblastic stronial reaction of the breast: Variations of collagenous matrix and structural glycoproteins. Virchows Arch 1985;408:49-59.
32. Gusterson BA, Warburton MJ, Mitchell D, Ellison M, Neville AM, Rudland PS: Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res 1982;42:4763-4770.
33. Monteagudo C, Merino M, SanJuan J, Liotta L, Stetler-Stevenson W: Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 1990;136:585-592.
34. Basset P, Wolf C, Rouyer N, Bellocq J, Rio M, Chambon P: Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior. Cancer 1994;74:1045-1049.
35. Guidi A, Fischer L, Harris J, Schnitt S: Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 1994;86:614-619.